Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease (COPD);Efecto del bromuro de ipratropio sobre la hiperinflación pulmonar dinámica en pacientes con enfermedad pulmonar obstructiva crónica

Revista Medica de Chile

Volumn 131, Issue 6, 2003, Pages 605-612

  Jorquera A, Jorge ^a   Díaz P , Orlando ^a   Lisboa B, Carmen ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Ipratropium; Lung diseases; Obstructive; Spirometry

Indexed keywords

IPRATROPIUM BROMIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; MALE; SPIROMETRY;

AGED; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; IPRATROPIUM; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REST; SPIROMETRY; WALKING;

EID: 12344337123     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. POSTMA DS, KOETER GH, WIJKSTRA PJ. Course and prognosis in patients with chronic airflow limitation and possible implications for therapy. En: Casaburi R, Petty TL, ed. Principles and practice of pulmonary rehabilitation. Filadelfia: Editorial WB Saunders Co., 1993; 138-50.
2. MEEK PM, SCHWARTZSTEIN RMS, ADAMS L, ALTOSE MD, BRESLIN EH, CARRIERI-KHOLMAN V ET AL. Dyspnea. Mechanisms, assessment and management: a consensus statement. Am J Respir Crit Care Med 1999; 159: 321-40.
3. PRIDE NB, MACKLEM PT. Lung mechanics in disease. En: Fishman AP, ed. Handbook of physiology, Section 3, Vol III, Part 2: The Respiratory System. Baltimore: Editorial William & Wilkins Company, 1986; 659-92.
4. O'DONNELL DE, BERTLEY JC, CHAU LL, WEBB KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation. Pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-15.
5. O'DONNELL DE, WEBB KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-7.
6. AMERICAN THORACIC SOCIETY. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 111-7.
7. SOLWAY S, BROOKS D, LACASSE Y, THOMAS S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiopulmonary domain. Chest 2001; 119: 256-70.
8. REID R, DÍAZ O, JORQUERA J, LISBOA C. Efecto de la prueba de la caminata de seis minutos sobre la hiperinflación pulmonar en pacientes con enfermedad pulmonar obstructiva crónica avanzada. Rev Méd Chile 2001; 129: 1171-8.
9. MARIN JM, CARRIZO SJ, GASCON M, SÁNCHEZ A, GALLEGO B, CELLI B. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395-9.
10. O'DONNELL DE, LAM M, WEBB KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 1999; 160: 542-9.
11. BONI E, CORDA L, FRANCHINI D, CHIROLI P, DAMIANI GP, PINI L ET AL. Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. Thorax 2002; 57: 528-32.
12. AMERICAN THORACIC SOCIETY. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-43.
13. AMERICAN THORACIC SOCIETY. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36.
14. O'DONNELL DE, LAM M, WEBB KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557-65.
15. KNUDSON RJ, LEBOWIST MD, HOLBERG CI, BURROWS BN. Changes in the normal maximal expiratory flow-volume curve with growth and age. Am Rev Respir Dis 1983; 127: 725-34.
16. QUANJER PH, TAMMELING GJ, COTES JE, PEDERSEN OF, PESLIN R, YERNAULT JC. Lung volumes and forced ventilatory flows. Report work party: Standardization of lung function testing. Eur Respir J 1993; 6 (Suppl 16): 5-40.
17. GUYATT GH, PUGSLEY SO, SULLIVAN MJ, THOMPSON PJ, BERMAN LB, JONES NL ET AL. Effect of encouragement on walking test performance. Thorax 1984; 39: 818-22.
18. BORG GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
19. ARMITAGE P, BERRY G. The simple crossover design. En: Armitage P and Berry G, ed. Statistical Methods in Medical Research. Londres: Editorial Blackwell Scientific Publications, 1994; 245-9.
20. ELLIASON O, DEGRAFF AC. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Am Rev Respir Dis 1985; 132: 858-64.
21. SIAFAKAS NM, VERMEIRE P, PRIDE NB, PAOLETTI P, GIBSON J, HOWARD P ET AL. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8: 1398-420.
22. O'DONNELL DE, FORKERT L, WEBB KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001; 18: 914-20.
23. BELMAN M, BOTNICK W, SHIN J. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-75.
24. TANTUCCI C, DUGUET A, SIMILOWSKY T, ZELTER M, DERENNE JP, MILIC-EMILI J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998; 12: 799-804.
25. DÍAZ O, VILLAFRANCA C, GHEZZO H, BORZONE G, LEIVA A, MILIC-EMILI J ET AL. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-75.
26. DÍAZ O, BEGIN P, TORREALBA B, JOVER E, LISBOA C. Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J 2002; 20: 1490-8.
27. SCIURBA FC, ROGERS RM, KEENAN RJ, SLIVKA WA, GORKSAN J, FERSON PF ET AL. improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996; 334: 1095-9.
28. STUBBING DG, PENGELLY LD, MORSE LC, JONES NL, Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-5.
29. DÍAZ O, VILLAFRANCA C, GHEZZO H, BORZONE G, LEIVA A, MILIC-EMILI J ET AL. Breathing pattern and gas exchange at peak exercise in COPD patients with and without tidal flow limitation at rest. Eur Respir J 2001; 17: 1120-7.